Synergy Pharmaceuticals Reports Third Quarter 2012 Financial Results

[at noodls] – Synergy Advances Clinical Programs NEW YORK, Nov. 13, 2012 — Synergy Pharmaceuticals, Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today reported its … more

View todays social media effects on SGYP

View the latest stocks trending across Twitter. Click to view dashboard